Skip Nav Destination
Nonmalignant late effects after allogeneic stem cell transplantation
Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia
Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia
Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies
Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family
The serine protease granzyme M is preferentially expressed in NK-cell, γδ T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity
Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone
Issue Archive
May 1 2003
In this Issue
Table of Contents
INSIDE BLOOD
BLOOD WORK
CONTROVERSIES IN HEMATOLOGY
PLENARY PAPERS
ERRATA
REVIEW ARTICLES
Nonmalignant late effects after allogeneic stem cell transplantation
Clinical Trials & Observations
Gérard Socié,Nina Salooja,Amnon Cohen,Attilio Rovelli,Enric Carreras,Anna Locasciulli,Elisabeth Korthof,Joachim Weis,Vincent Levy,André Tichelli,for the Late Effect Working Party of the European Group for Blood and Marrow Transplantation
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia
Clinical Trials & Observations
Takafumi Matsushima,Hiroshi Handa,Akihiko Yokohama,Jun Nagasaki,Hiromi Koiso,Yoshitora Kin,Yoko Tanaka,Tohru Sakura,Norifumi Tsukamoto,Masamitsu Karasawa,Katsuhiko Itoh,Hisami Hirabayashi,Morio Sawamura,Shogo Shinonome,Shun-ichi Shimano,Shuichi Miyawaki,Yoshihisa Nojima,Hirokazu Murakami
Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia
Clinical Trials & Observations
Eric L. Sievers,Beverly J. Lange,Todd A. Alonzo,Robert B. Gerbing,Irwin D. Bernstein,Franklin O. Smith,Robert J. Arceci,William G. Woods,Michael R. Loken
Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies
Clinical Trials & Observations
Brief Report
Stefan Faderl,Deborah A. Thomas,Susan O'Brien,Guillermo Garcia-Manero,Hagop M. Kantarjian,Francis J. Giles,Charles Koller,Alessandra Ferrajoli,Srdan Verstovsek,Barbara Pro,Michael Andreeff,Miloslav Beran,Jorge Cortes,William Wierda,Ngoc Tran,Michael J. Keating
GENE THERAPY
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
A naturally occurring Tyr143HisαIIb mutation abolishes αIIbβ3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects
Teruo Kiyoi,Yoshiaki Tomiyama,Shigenori Honda,Seiji Tadokoro,Morio Arai,Hirokazu Kashiwagi,Satoru Kosugi,Hisashi Kato,Yoshiyuki Kurata,Yuji Matsuzawa
Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family
Clinical Trials & Observations
Brief Report
IMMUNOBIOLOGY
Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration
Rong Dong,Kate Cwynarski,Alan Entwistle,Federica Marelli-Berg,Francesco Dazzi,Elizabeth Simpson,John M. Goldman,Junia V. Melo,Robert I. Lechler,Ilaria Bellantuono,Anne Ridley,Giovanna Lombardi
The serine protease granzyme M is preferentially expressed in NK-cell, γδ T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity
Clinical Trials & Observations
Brief Report
Laszlo Krenacs,Mark J. Smyth,Eniko Bagdi,Tibor Krenacs,Laszlo Kopper,Thomas Rudiger,Andreas Zettl,Hans Konrad Muller-Hermelink,Elaine S. Jaffe,Mark Raffeld
NEOPLASIA
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
Anne-Marie O'Farrell,Tinya J. Abrams,Helene A. Yuen,Theresa J. Ngai,Sharianne G. Louie,Kevin W. H. Yee,Lily M. Wong,Weiru Hong,Leslie B. Lee,Ajia Town,Beverly D. Smolich,William C. Manning,Lesley J. Murray,Michael C. Heinrich,Julie M. Cherrington
Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays
Dharminder Chauhan,Guilan Li,Daniel Auclair,Teru Hideshima,Paul Richardson,Klaus Podar,Nicholas Mitsiades,Constantine Mitsiades,Cheng Li,Ryung Suk Kim,Nikhil Munshi,Lan Bo Chen,Wing Wong,Kenneth C. Anderson
Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone
Clinical Trials & Observations
Marianne Konrad,Markus Metzler,Simon Panzer,Iris Östreicher,Martina Peham,Reinald Repp,Oskar A. Haas,Helmut Gadner,E. Renate Panzer-Grümayer
TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome–positive leukemia cells
Kanako Uno,Takeshi Inukai,Nobuhiko Kayagaki,Kumiko Goi,Hiroki Sato,Atsushi Nemoto,Kazuya Takahashi,Keiko Kagami,Noriko Yamaguchi,Hideo Yagita,Ko Okumura,Toshiko Koyama-Okazaki,Toshio Suzuki,Kanji Sugita,Shinpei Nakazawa
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma
Thomas F. E. Barth,José I. Martin-Subero,Stefan Joos,Christiane K. Menz,Cornelia Hasel,Gunhild Mechtersheimer,Reza M. Parwaresch,Peter Lichter,Reiner Siebert,Peter Möller
PHAGOCYTES
RED CELLS
TRANSFUSION MEDICINE
TRANSPLANTATION
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals